Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses

Journal of General Virology

Volumn 79, Issue 9, 1998, Pages 2191-2201

  Klein, Michèl R ^a,d   Van Der Burg, Sjoerd H ^b   Hovenkamp, Egbert ^a   Holwerda, Agnes M ^a   Drijfhout, Jan Wouter ^b   Melief, Cornelis J M ^b   Miedema, Frank ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HLA B ANTIGEN;

ARTICLE; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031709899     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-9-2191     Document Type: Article

References (50)

1. Barber, L. D., Percival, L., Arnett, K. L., Gumperz, J. E., Chen, L. & Parham, P. (1997). Polymorphisms in the α1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. Journal of Immunology 158, 1660.
2. Bertoletti, A., Cham, F., McAdam, S., Rostron, T., Rowland-Jones, S., Sabally, S., Corrah, T., Ariyoshi, K. & Whittle, H. (1998). Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades. Journal of Virology 72, 2439-2448.
3. Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M. & Oldstone, M. B. A. (1994). Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. Journal of Virology 68, 6103-6110.
4. Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A. & Shaw, G. M. (1997). Antiviral pressure exerted by HIV-1 specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Medicine 3, 205-211.
5. Buseyne, F., Fevrier, M., Garcia, S., Gougeon, M. L. & Rivière, Y. (1996). Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte clone: inhibition of HIV replication by nonlytic mechanisms and lysis of HIV-infected CD4+ cells. Virology 225, 240-253.
6. Centers for Disease Control and Prevention (1993). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Mortality and Morbidity Weekly Report 41, 1-19.
7. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C. & Lusso, P. (1995). Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-1815.
8. De Roda Husman, A. M., Koot, M., Cornelissen, M., Keet, I. P. M., Brouwer, M., Broersen, S. M., Bakker, M., Roos, M. T. L., Prins, M., De Wolf, F., Coutinho, R. A., Miedema, F., Goudsmit, J. & Schuitemaker, H. (1997). Association between CCR5 genotype and the clinical course of HIV-1 infection. Annals of Internal Medicine 127, 882-890.
9. Falk, K., Rötzschke, O., Takiguchi, M., Gnau, V., Stevanovic, S., Jung, G. & Rammensee, H. G. (1995). Peptide motifs of HLA-B58, B60, and B62 molecules. Immunogenetics 41, 165-168.
10. Goulder, P. J. R., Bunce, M., Krausa, P., McIntyre, K., Crowley, S., Morgan, B., Edwards, A., Giangrande, P., Phillips, R. E. & McMichael, A. J. (1996). Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type-1 infection. AIDS Research and Human Retroviruses 12, 1691-1698.
11. Goulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgan, B., Edwards, A., McMichael, A. J. & Rowland-Jones, S. (1997). Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Medicine 3, 212-217.
12. Guy, B., Kieny, M. P., Rivière, Y., LePeuch, C., Dott, K., Girard, M., Montagnier, L. & Lecocq, J. P. (1987). HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330, 266-269.
13. Haas, G., Plikat, U., Debré, P., Lucchiari, M., Katlama, C., Dudoit, Y., Bonduelle, O., Bauer, M., Ihlenfeldt, H. G., Jung, G., Maier, B., Meyerhans, A. & Autran, B. (1996). Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. Journal of Immunology 157, 4212-4221.
14. Haldane, J. B. S. (1955). The estimation and significance of the logarithm of a ratio of frequencies. Annals of Human Genetics 20, 309-311.
15. Harrer, T., Harrer, E., Kalams, S. A., Elbeik, T., Staprans, S. I., Feinberg, M. B., Cao, Y., Ho, D. D., Yilma, T., Caliendo, A. M., Johnson, R. P., Buchbinder, S. P. & Walker, B. D. (1996). Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable non-progressing HIV type-1 infection. AIDS Research and Human Retroviruses 12, 585-592.
16. Haynes, B. F., Pantaleo, G. & Fauci, A. S. (1996). Toward an understanding of the correlates of protective immunity to HIV infection. Science 271, 324-328.
17. Imanishi, T., Akaza, T., Kimura, A., Tokunaga, K. & Gojobori, T. (1992). Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop and Conference held in Yokohama, pp. 1065-1220. Edited by K. Tsuji, M. Aizawa & T. Sasazuki. Oxford: Oxford University Press.
18. Itescu, S., Mathur, W. U., Skovron, M. L., Brancato, L. J., Marmor, M., Zeleniuch, J. A. & Winchester, R. (1992). HLA-B35 is associated with accelerated progression to AIDS. Journal of Acquired Immune Deficiency Syndromes 5, 37-45.
19. Johnson, R. P., Trocha, A., Yang, L., Mazzara, G. P., Panicali, D. L., Buchanan, T. M. & Walker, B. D. (1991). HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes: fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. Journal of Immunology 147, 1512-1521.
20. Kalams, S. A., Johnson, R. P., Trocha, A. K., Dynan, M. J., Ngo, H. S., D'Aquila, R. T., Kurnick, J. T. & Walker, B.D. (1994). Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. Journal of Experimental Medicine 179, 1261-1271.
21. Kaslow, R. A., Duquesnoy, R., Van Raden, M., Kingsley, L., Marrari, M., Friedman, H., Su, S., Saah, A. J., Detels, R., Phair, J. P. & Rinaldo, C. (1990). A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. Lancet 335, 927-930.
22. Kaslow, R. A., Carrington, M., Apple, R., Park, L., Munoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C., Detels, R., Blattner, W., Phair, J. P., Erlich, H. & Mann, D. L. (1996). Influence of combinations of human major histocompatibility complex genes in the course of HIV-1 infection. Nature Medicine 2, 405-411.
23. Keet, I. P. M., Klein, M. R., Just, J. & Kaslow, R. A. (1996). The role of host genetics in the natural history of HIV-1 infection: the needles in the haystack. AIDS 10 (Suppl. A), S59-S67.
24. Klein, M. R. & Miedema, F. (1995). Long-term survivors of HIV-1 infection. Trends in Microbiology 3, 386-391.
25. Klein, M. R., Keet, I. P. M., D'Amaro, J., Bende, R. J., Hekman, A., Mesman, B., Koot, M., de Waal, L. P., Coutinho, R. A. & Miedema, F. (1994). Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam Cohort of homosexual men. Journal of Infectious Diseases 169, 1244-1249.
26. Klein, M. R., Van Baalen, C. A., Holwerda, A. M., Kerkhof-Garde, S. R., Bende, R. J., Keet, I. P. M., Eeftinck Schattenkerk, J. K. M., Osterhaus, A. D. M. E., Schuitemaker, H. & Miedema, F. (1995). Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. Journal of Experimental Medicine 181, 1365-1372.
27. Klein, M. R., Van der Burg, S. H., Pontesilli, O. & Miedema F. (1998). Cytotoxic T lymphocytes in HIV-1 infection, a killing paradox? Immunology Today (in press).
28. Koenig, S., Conley, A. J., Brewah, Y. A., Jones, G. M., Leath, S., Boots, L. J., Davey, V., Pantaleo, G., Demarest, J. F., Carter, C., Wannebo, C., Yannelli, J. R., Rosenberg, S. A. & Clifford Lane, H. (1995). Transfer of HIV-1 specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nature Medicine 1, 330-336.
29. + cell depletion and progression to AIDS. Annals of Internal Medicine 118, 681-688.
30. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. & Ho, D. D. (1994). Temporal associations of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 68, 4650-4655.
31. Lefkovits, I. & Waldmann, H. (1984). Limiting dilution analysis of the cells of immune system. I. The clonal basis of the immune response. Immunology Today 5, 265-268.
32. McChesney, M., Tanneau, F., Regnault, A., Sansonetti, P., Montagnier, L., Kieny, M. P. & Rivière, Y. (1990). Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence. European Journal of Immunology 20, 215-220.
33. Mortara, L., Letourneur, F., Gras-Masse, H., Venet, A., Guillet, J. G. & Bourgault-Villada, I. (1998). Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine. Journal of Virology 72, 1403-1410.
34. Myers, G., Hahn, B. H., Henderson, L. E., Korber, B. T. M., Jeang, K. T., McCutchan, F. E. & Pavlakis, G. N. (1995). Human Retroviruses and AIDS 1995: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos, NM: Los Alamos National Laboratory.
35. Plata, F., Autran, B., Martins, L. P., Wain-Hobson, S., Raphael, M., Mayaud, C., Denis, M., Guillon, J. M. & Debre, P. (1987). AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 328, 348-351.
36. Price, D. A., Goulder, P. J., Klenerman, P., Sewell, A. K., Easterbrook, P. J., Troop, M., Bangham, C. R. & Phillips, R. E. (1997). Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proceedings of the National Academy of Sciences, USA 94, 1890-1895.
37. Rautmann, G., Kieny, M. P., Brandely, R., Dott, K., Girard, M., Montagnier, L. & Lecocq, J. P. (1989). HIV-1 core proteins expressed from recombinant vaccinia viruses. AIDS Research and Human Retroviruses 5, 147-157.
38. Sahmoud, T., Laurian, Y., Gazengel, C., Sultan, Y., Gautreau, C. & Costagliola, D. (1993). Progression to AIDS in French haemophiliacs: association with HLA-B35. AIDS 7, 497-500.
39. Schuitemaker, H., Kootstra, N. A., De Goede, R. E. Y., De Wolf, F., Miedema, F. & Tersmette, M. (1991 ). Monocytotropic human immunodeficiency virus 1 (HIV-1) variants detectable in all stages of HIV infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. Journal of Virology 65, 356-363.
40. Sipsas, N. V., Kalams, S. A., Trocha, A., He, S., Blattner, W. A., Walker, B. D. & Johnson, R. P. (1997). Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. Journal of Clinical Investigation 99, 752-762.
41. Strijbosch, L. W. G., Buurman, W. A., Does, R. J. M. M., Zinken, P. H. & Groenewegen, G. (1987). Limiting dilution assays. Experimental design and statistical analysis. Journal of Immunological Methods 97, 133-140.
42. Tsubota, H., Lord, C. I., Watkins, D. I., Morimoto, C. & Letvin, N. L. (1989). A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. Journal of Experimental Medicine 169, 1421-1434.
43. Van Baalen, C. A., Klein, M. R., Geretti, A. M., Keet, I. P. M., Miedema, F., Van Els, C. A. C. M. & Osterhaus, A. D. M. E. (1993). Selective in vitro expansion of HLA class I-restricted HIV-1 gag specific CD8+ T cells from seropositive individuals: identification of CTL epitopes and precursor frequencies. AIDS 7, 781-786.
44. Van Baalen, C. A., Pontesilli, O., Huisman, R. C., Geretti, A. M., Klein, M. R., De Wolf, F., Miedema, F., Gruters, R. A. & Osterhaus, A. D. (1997). Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. Journal of General Virology 78, 1913-1918.
45. Van de Griend, R. J., Van Krimpen, B. A., Bol, S. J. L., Thompson, A. & Bolhuis, R. L. H. (1984). Rapid expansion of human cytotoxic T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cells. Journal of Immunological Methods 66, 285-298.
46. Van der Burg, S. H., Klein, M. R., Van de Velde, C. J. H., Kast, W. M., Miedema, F. & Melief, C. J. M. (1995 a). Induction of primary human CTL response against a novel conserved epitope in a functional sequence of HIV-1 reverse-transcriptase. AIDS 9, 121-127.
47. Van der Burg, S. H., Ras, E., Drijfhout, J. W., Benckhuijsen, W. E., Bremers, A. J. A., Melief, C. J. M. & Kast, W. M. (1995b). An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells: identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301. Human Immunology 44, 189-198.
48. Van der Burg, S. H., Klein, M. R., Pontesilli, O., Holwerda, A. M., Drijfhout, J. W., Kast, W. M., Miedema, F. & Melief, C. J. M. (1997). HIV-1 reverse transcriptase-specific cytotoxic T lymphocytes targeted at epitopes under structural or functional constraints do not protect against progression to AIDS. Journal of Immunology 159, 3648-3654.
49. Walker, C. M., Moody, D. J., Stites, D. P. & Levy, J. A. (1986). CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234, 1563-1566.
50. Walker, B. D., Chakrabarti, S., Moss, B., Paradis, T. J., Flynn, T., Durno, A. G., Blumberg, R. S., Kaplan, J. C., Hirsch, M. S. & Schooley, R. T. (1987). HIV-1 specific cytotoxic T lymphocytes in seropositive individuals. Nature 328, 345-348.